1383775-76-5

Upstream product

• 1383775-77-6 tert-butyl 2-((3-chlorophenyl)amino)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 157327-41-8 t-butyl-3-[(dimethylamino)methylidene]-4-oxopiperidine-1-carboxylate 

Downstream Products

• 1383776-09-7 N-(3-chlorophenyl)-6-(pyridin-2-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 1383776-04-2 2-((3-chlorophenyl)amino)-N-ethyl-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxamide 
• 1383776-10-0 6-(1-(tert-butyl)-1H-tetrazol-5-yl)-N-(3-chlorophenyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 1383776-12-2 N-(3-chlorophenyl)-6-(1-isopropyl-1H-tetrazol-5-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 

Relevant academic research and scientific papers

METABOTROPIC GLUTAMATE RECEPTOR MODULATORS

The invention relates to heterocyclic derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are m GluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.